| [1] |
LIN Jingyi, HAN Rangyue, XU Linghui, TAN Ruizhi, SU Hongwei, WANG Li.
Huangqi sanqi mixture inhibits lncRNA Gm51500/Adam12 axis to improve renal fibrosis in CKD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 750-762.
|
| [2] |
LI Mingqi, WANG Yinghe, ZHAO Xiaolu, BAO Xiaomei, YUE Xin, REN Guiqiang, MA Yuehong.
Mechanism of total flavonoids of Carthamus tinctorius L.against hepatic fibrosis based on LC-MS/MS combined with network pharmacology and pharmacology experiments
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 586-598.
|
| [3] |
LI Wen, JIANG Hugang, WANG Xinqiang, LI Yingdong, LIU Kai, ZHAO Xinke.
Radix angelica sinensis and astragalus mongholicus extract mediating the Jagged1/Notch1 pathway to inhibit fibroblast transdifferentiation and resist radiation induced myocardial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 209-215.
|
| [4] |
YU Xiaohai, JIN Yu, SUN Minqiong, CONG Hui, GUO Qianying.
Ameliorating effect of total flavonoids of rhododendron on brain oxidative stress injury in cerebral ischemia-reperfusion rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 216-221.
|
| [5] |
LI Hui, HU Hengzhao, YU Tingting, HU Huixian, WANG Jiale, WU Jing, HAO Wei.
Plumbagin ameliorates pulmonary fibrosis by modulating TGF-β1/Smad2 and Nrf2/NOX4 pathways
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 61-69.
|
| [6] |
LEI Guojie, YU Yanhua, LIU Yingchao, BIAN Wenxia, DU Jing, TONG Xiangmin.
Mechanism of PX-12 induced apoptosis of hepatocellular carcinoma cells through oxidative stress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 961-967.
|
| [7] |
NI Jie, HONG Xiaodan, JI Ke, JIA Yuanwei, WANG Guangji, ZHANG Jingwei.
Influence of hepatitis B combined with hepatic fibrosis on endogenous and exogenous metabolism and therapeutic implications
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 853-860.
|
| [8] |
WU Xiaoxue, YE Yiping, LEI Zhendong, ZHANG Zunjing, CHEN Wenling.
Icariin improves hypertensive renal fibrosis and injury through Cx32-Nox4 signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 870-878.
|
| [9] |
LI Zepeng, GU Wenqiang, CHEN Xiao, WANG Yinhua, LI Xianwei.
Protective efficacy of epalrestat on mitochondrial oxidative stress damage for radiation pneumonitis in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 809-818.
|
| [10] |
LI Wen, JIANG Hugang, WANG Xinqiang, LI Yingdong, LIU Kai, ZHAO Xinke.
Exploring the mechanism of Radix Angelica sinensis and Astragalus mongholicus extract therapy for radiationinduced myocardial fibrosis based on network pharmacology and experimental validation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 601-611.
|
| [11] |
CHEN Feng, LI Long, WANG Jie, LIU Shengfei.
Research progress on CXC chemokines and their receptors and pulmonary fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 583-589.
|
| [12] |
ZHAO Tingting, LI Junfeng, ZHANG Liting.
Progress in the potential therapeutic mechanism of mesenchymal stem cell-derived exosomes for liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 475-480.
|
| [13] |
YU Dan, LIU Zongtao, YAN Xiaohong, CHENG Jing, LI lin.
Effects of osthole on renal oxidative stress injury in aged spontaneously hypertensive rats by regulating PI3K/Akt/mTOR signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 277-282.
|
| [14] |
ZHANG Yanni, DUAN Yuxin, BAI Yi, YU Jinyao, SUN Jiayi, WANG Zejie, LI Ling, YE Qifa.
Novel mechanisms driving renal tubulointerstitial fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 348-353.
|
| [15] |
YU Jiawang, YU Tingting, GAO Huaxin, KE Jie, YIN Xian.
Effects of melittin on acute lung injury in mice based on TLR4/NF-kB signaling pathway
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(11): 1232-1239.
|